Keymed Biosciences Inc. (HKG:2162)
Hong Kong · Delayed Price · Currency is HKD 77.75
+0.70 (0.91%)
Aug 20, 2026, 4:09 PM HKT
Keymed Biosciences Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, Keymed Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $100.08. The average 1-year stock price forecast is 28.72% higher than the current stock price, while the lowest is $90.18 (+15.99%) and the highest is $110.36 (+41.94%).
Price Target: $100.08 (+28.72%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Keymed Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 6 | 6 | 7 | 8 | 9 |
| Buy | 3 | 3 | 4 | 4 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 9 | 10 | 11 | 13 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Daiwa No rating | Daiwa | Buy Maintains $101.00 | Buy | Maintains | $101.00 | +29.90% | Aug 12, 2026 |
Unknown Analyst Guotai Haitong No rating | Guotai Haitong | Buy Maintains $138.91 | Buy | Maintains | $138.91 | +78.66% | Jul 10, 2026 |
Unknown Analyst Shenwan Hongyuan No rating | Shenwan Hongyuan | Buy Maintains $89.47 | Buy | Maintains | $89.47 | +15.07% | May 28, 2026 |
Unknown Analyst Morgan Stanley No rating | Morgan Stanley | Buy Maintains $97.00 | Buy | Maintains | $97.00 | +24.76% | May 28, 2026 |
Unknown Analyst KeyBanc No rating | KeyBanc | Buy Maintains $87.31 | Buy | Maintains | $87.31 | +12.30% | Apr 4, 2026 |
Financial Forecast
Revenue This Year
2.26B
from 716.31M
Increased by 215.96%
Revenue Next Year
2.13B
from 2.26B
Decreased by -6.09%
EPS This Year
3.35
from -1.81
EPS Next Year
0.50
from 3.35
Decreased by -85.06%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.